Resveratrol Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice With Induced Adenomyosis
Authors:
- 1 November 2015
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 22 (11) , 1336-1349
Abstract
In this study, we sought to determine whether resveratrol (RSV), a nonhormonal compound, would suppress the myometrial infiltration, improve pain behavior, lower stress level, improve the expression of some proteins known to be involved in adenomyosis, and reduce uterine contractility in a mice model of adenomyosis. Adenomyosis was induced in 28 female ICR mice neonatally dosed with tamoxifen, while another 12 (group C) were dosed with solvent only, serving as a blank control. Starting from 4 weeks after birth, hotplate test was administrated to all mice every 4 weeks. At the 16th week, all mice with induced adenomyosis were randomly divided into 3 groups: low-dose RSV (2 mg/kg), high-dose RSV (3 mg/kg), and untreated. Group C received no treatment. After 3 weeks of treatment, they were hotplate tested again, their uterine horns and brains were harvested, and a blood sample was taken to measure the plasma corticosterone (CORT) level by enzyme-linked immunosorbent assay. The left uterine horn was used for immunohistochemistry analysis. The brain stem nucleus raphe magnus (NRM) sections were subjected to immunofluorescence staining for glutamic acid decarboxylase isoform 65 (GAD65). The depth of myometrial infiltration and uterine contractility was evaluated. We found that RSV is well tolerated and that it dose dependently suppressed myometrial infiltration, improved generalized hyperalgesia, reduced uterine contractility and lowered plasma CORT levels, and improved the expression of some proteins known to be involved in adenomyosis. It also elevated the number of GAD65-expressing neurons in the brain stem NRM, possibly boosting the GABAergic inhibition of pain due to adenomyosis. Therefore, RSV appears to be a promising compound for treating adenomyosis.Keywords
This publication has 48 references indexed in Scilit:
- Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved HyperalgesiaReproductive Sciences, 2014
- Epigallocatechin-3-Gallate Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice Induced With AdenomyosisReproductive Sciences, 2013
- Natural therapies assessment for the treatment of endometriosisHuman Reproduction, 2012
- The Retardation of Myometrial Infiltration, Reduction of Uterine Contractility, and Alleviation of Generalized Hyperalgesia in Mice With Induced Adenomyosis by Levo-Tetrahydropalmatine (l-THP) and AndrographolideReproductive Sciences, 2011
- Resveratrol Inhibits Development of Experimental Endometriosis In Vivo and Reduces Endometrial Stromal Cell Invasiveness In Vitro1Biology of Reproduction, 2011
- Resveratrol: A multitargeted agent for age-associated chronic diseasesCell Cycle, 2008
- Pathology and physiopathology of adenomyosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancerExperimental and Toxicologic Pathology, 2005
- Adenomyosis—A Result of Disordered Stromal DifferentiationThe American Journal of Pathology, 2001
- Adenomyosis: Difficult to Diagnose, and Difficult to TreatDiagnostic and Therapeutic Endoscopy, 2000